The cost of isavuconazonium sulfate, marketed as Cresemba, varies significantly based on factors such as insurance coverage, pharmacy, and geographic location [1].
How much does a typical Cresemba prescription cost?
Without insurance, a 30-day supply of Cresemba can range from approximately $5,000 to over $10,000 [2][3]. For instance, one source indicates a price around $5,600 for a 30-day supply of the oral formulation [2]. The intravenous formulation may also fall within this price range [3].
Are there patient assistance programs for Cresemba?
Yes, Astellas Pharma, the manufacturer of Cresemba, offers patient assistance programs. The Cresemba Co-Pay Card program can help eligible patients reduce their out-of-pocket costs for the medication. For commercially insured patients, savings can be as high as $50 per dose or $150 per month, with an annual cap of $4,000 [4]. Eligibility criteria apply, and the program is not available to patients with government-funded insurance like Medicare or Medicaid [4].
How does insurance affect the price of isavuconazonium sulfate?
Insurance coverage plays a crucial role in the out-of-pocket cost for patients. With good insurance, co-pays can be significantly lower, sometimes ranging from $0 to $50 per prescription [1][3]. However, coverage details vary by plan, and some patients may still face substantial co-insurance or deductibles [3].
What is the difference between oral and IV Cresemba costs?
While both the oral capsules and the intravenous solution of Cresemba are used to treat serious fungal infections, their pricing can be similar. Cost discussions often encompass both formulations, with the overall expense for a treatment course being a primary concern for patients and healthcare providers [2][3].
Where can I find the most current pricing information?
Patients and healthcare providers can obtain the most up-to-date pricing information from their pharmacist or by contacting Astellas Pharma directly. Manufacturer websites and patient assistance program portals also provide relevant details regarding cost and support [4].